Cardiometabolic & renal · Live ClinicalTrials.gov data

Empagliflozin (Jardiance) clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 empagliflozin (Jardiance) trials on ClinicalTrials.gov by enrolment, 2 of them actively recruiting. The next phase 3 primary completion among them is expected Apr 2027. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

8

Phase 3 trials

2

Actively recruiting

Apr 2027

Next phase 3 primary completion

13,365

Participants across trials

Boehringer Ingelheim

Lead sponsor by trial count

empagliflozin (16)7 active2008–2029
empagliflozin
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingEnrolling by invitationCompletedUnknown status
'08
'10
'12
'14
'16
'18
'20
'22
'24
'26
'28
empagliflozin
12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic PatientsP2
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).P3
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 DiabetesP3
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)P3
EMPA-HEARTP4
The Effects of Empagliflozin on Arterial Wall CharacteristicsP4
SUGAR-DM-HFP4
Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study ProtocolP4
A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart FailureP3
The CANA -AHFP3
EMPAP3
SGLT2i VS ACEiP2
Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese PatientP4
STEPSP4
TIME-SGLT2P3
EMPA-CONP3

Upcoming readouts

2 ahead · empagliflozin

Select a trial to load its full ClinicalTrials.gov record.

Key empagliflozin trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

TrialTitlePhaseStatusPrimary completion
NCT06668389STEPS: Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancem…Phase 4RecruitingDec 2026
NCT03485092SUGAR-DM-HF: Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic EffectsPhase 4CompletedMar 2020
NCT03560375Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: …Phase 4CompletedFeb 2021
NCT06145360Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Me…Phase 4CompletedMar 2024
NCT02998970EMPA-HEART: Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 DiabetesPhase 4UnknownSept 2018
NCT03639545The Effects of Empagliflozin on Arterial Wall CharacteristicsPhase 4UnknownDec 2018
NCT07038356EMPA-CON: Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SG…Phase 3RecruitingApr 2027
NCT07065357TIME-SGLT2: Treating the Metabolic Syndrome With a Sodium-glucose Cotransporter-2 InhibitorPhase 3Enrolling by invitationAug 2026
NCT01289990Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in …Phase 3CompletedMay 2013
NCT01131676BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients…Phase 3CompletedApr 2015
NCT02414958Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Me…Phase 3CompletedApr 2017
NCT04157751A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Fail…Phase 3CompletedMay 2021

Track empagliflozin with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track empagliflozin

FAQ

How many clinical trials are running for empagliflozin?
ClinicalTrials.gov lists more than 16 phase 2–4 empagliflozin trials. This page tracks the 16 largest by enrolment: 2 phase 2, 8 phase 3, and 6 phase 4 among them, with 2 actively recruiting. Updated daily.
Are there clinical trials for Jardiance?
Jardiance is the brand name for empagliflozin, so empagliflozin trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 empagliflozin trials. This page tracks the 16 largest by enrolment: 2 phase 2, 8 phase 3, and 6 phase 4 among them, with 2 actively recruiting. Updated daily.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare empagliflozin against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.

Keep following
what matters.

Choose the drugs, companies or disease areas you follow. Bring trial changes and upcoming readouts into one watch.

Build your watch

Choose what to track in the watch builder.